F&P Healthcare FY25 guidance to be in the spotlight

F&P Healthcare FY25 guidance to be in the spotlight
F&P Healthcare expects its emerging anaesthesia business will continue to grow quickly. (Image: Fisher & Paykel Healthcare)
Rebecca Howard
Fisher & Paykel Healthcare’s guidance for the 2025 financial year will be of keen interest when it reports on May 29.“With FPH having pre-announced its FY24 result, the key question when FPH reports will be guidance for FY25,” said Craigs Investment Partners analysts Stephen Ridgewell and Rob Morrison.In early March the healthcare products manufacturer said it expected full-year operating revenue would be approximately $1.73 billion for the year to March 31.It forecast underlying profit after tax (excluding any fair v...

More Markets

NZ sharemarket up 0.1% on flat trading day
Markets Market close

NZ sharemarket up 0.1% on flat trading day

The S&P/NZX 50 Index closed at 11,790.92, up 14.18 points or 0.12%.

Advent International eyes NZ deals with Aussie outpost
Markets

Advent International eyes NZ deals with Aussie outpost

US private equity giant says NZ key market for growth.

These shares are 'priced for awful'
Markets

These shares are 'priced for awful'

Kathmandu, SkyCity and Fletcher shares are under pressure. Some are taking the plunge.